[go: up one dir, main page]

GB1054698A - - Google Patents

Info

Publication number
GB1054698A
GB1054698A GB1054698DA GB1054698A GB 1054698 A GB1054698 A GB 1054698A GB 1054698D A GB1054698D A GB 1054698DA GB 1054698 A GB1054698 A GB 1054698A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
acid
ascorbic acid
salt
cackets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of GB1054698A publication Critical patent/GB1054698A/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,054,698. Pharmaceutical composition containing salts of ascorbic acid. N. J. FLOWER. Nov. 29, 1965 [Dec. 4, 1964], No. 49330/64. Heading A5B. A pharmaceutical composition comprises as active ingredients potassium ascorbate, a magnesium salt of ascorbic acid, and optionally glucose or a salt of carnitine, thiamine, methylamphetamine, riboflavin, niacin, niacinamide, pyridoxine, pantothenic acid, biotin, folic acid, cyanocobalamin or calciferol. The compositions are administered orally in the form of tablets, capsules, sachets, cackets, pastilles, troches or lozenges.
GB1054698D 1964-12-04 Active GB1054698A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4933064 1964-12-04

Publications (1)

Publication Number Publication Date
GB1054698A true GB1054698A (en)

Family

ID=10451983

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1054698D Active GB1054698A (en) 1964-12-04

Country Status (3)

Country Link
BE (1) BE673254A (en)
FR (1) FR5013M (en)
GB (1) GB1054698A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414212A (en) * 1981-12-10 1983-11-08 Graham J. Naylor Method of treatment of pre-menstrual syndrome
US4704352A (en) * 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
WO1999053921A1 (en) * 1998-04-17 1999-10-28 Sigma-Tau Healthscience S.P.A. Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
WO2015176848A1 (en) * 2014-05-21 2015-11-26 Bauer K H Self-drying dosage form with controllable drying time and drying rate

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414212A (en) * 1981-12-10 1983-11-08 Graham J. Naylor Method of treatment of pre-menstrual syndrome
US4704352A (en) * 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
WO1999053921A1 (en) * 1998-04-17 1999-10-28 Sigma-Tau Healthscience S.P.A. Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
AU750645B2 (en) * 1998-04-17 2002-07-25 Sigma-Tau Healthscience S.P.A. Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH
WO2015176848A1 (en) * 2014-05-21 2015-11-26 Bauer K H Self-drying dosage form with controllable drying time and drying rate

Also Published As

Publication number Publication date
BE673254A (en) 1966-06-03
FR5013M (en) 1967-04-24

Similar Documents

Publication Publication Date Title
IL36079A0 (en) 4-morpholino-thieno (3,2-d) pyrimidine derivatives,their production and pharmaceutical compositions containing them
OA04297A (en) Spring for receptacles intended to receive and deliver one by one articles, in particular tablets.
IL36018A0 (en) New 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them
IL35078A (en) 2-aminoalkylamino-thieno (3,2-d) pyrimidines and their salts,their preparation and pharmaceutical compositions containing them
GB975387A (en) Multivitamin compositions
GB1054698A (en)
GB1247801A (en) Pharmaceutical compositions
GB1356097A (en) Mineral salt preparation
DK123141B (en) Process for stabilizing a pharmaceutical composition suitable for oral administration, containing a basic dihydrodibenzazepine.
GB1344558A (en) Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
CA1005342A (en) Pharmaceutical composition containing nicotinic acid derivatives
GB1202148A (en) Pharmaceutical compositions
ES255922A1 (en) New piperazine derivative
GB1289096A (en)
GB1187946A (en) Dimethylbiguanide Derivative
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
IL34938A0 (en) Pharmaceutical compositions containing a 2,4-thiazolidine-dione-2 thiosemicarbazone derivatives
ES264510A1 (en) Improvements in or relating to pharmaceutical iron preparations
IL30696A0 (en) Phenazine derivatives,processes for their preparation and pharmaceutical compositions containing them
GB1263839A (en) A novel aminoethanesulfonic acid
GB1153324A (en) Sustained Release Tablets
FI51900C (en) A process for the preparation of tablets in which the active substance dissolves slowly.
JPS5316274A (en) Three-dimensional warehouse
GB1336609A (en) Antismoking preparation
IL31294A0 (en) A new(hexafluoro-3,5-xylyl)-anthranilic acid and its salts,their preparation,and pharmaceutical compositions containing them